World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
14600
World Ranking
3022
National Ranking
1416

Dharam V. Ablashi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dharam V. Ablashi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 233 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dharam V. Ablashi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dharam V. Ablashi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dharam V. Ablashi is affiliated with Georgetown University in the United States and focuses primarily on research within the field of Medicine. Their work spans several subfields, including Infectious Diseases, Nutrition and Dietetics, Molecular Biology, and Immunology. This diverse range reflects a broad engagement with topics relevant to health sciences and biomedical research.

Their recent scholarly output includes studies published in specialized journals. Notable papers comprise "Transfer Factor as an Option for Managing the COVID-19 Pandemic," published in 2020 in Folia Biologica, and "The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures," published in 2023 in Veterinary Medicine and Science. These publications indicate an interest in viral diseases and their clinical and therapeutic implications.

Their work addresses several interconnected themes, such as:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral gastroenteritis research and epidemiology
  • Food Science and Nutritional Studies
  • Plant tissue culture and regeneration
  • Toxin Mechanisms and Immunotoxins

Throughout their research career, Ablashi has collaborated with various co-authors, including D. Viza, Giovanni Pizza, Concetta Vinci, Giovanni Brandi, and Katalin Réka Tarcsai. These collaborations span different projects and represent professional partnerships within overlapping research interests.

The primary venues for their publications include Folia Biologica and Veterinary Medicine and Science, reflecting the interdisciplinary and translational nature of their work. These journals serve as platforms for disseminating findings related to infectious diseases and veterinary aspects of viral infections.

Best Publications

  • Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

    SZ Salahuddin;DV Ablashi;PD Markham;SF Josephs

  • A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

    Dedra Buchwald;Paul R. Cheney;Daniel L. Peterson;Berch Henry

  • Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases

    Dharam V. Ablashi;Louise G. Chatlynne;James E. Whitman;Ethel Cesarman

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

    Jesse H. Arbuckle;Maria M. Medveczky;Janos Luka;Stephen H. Hadley

  • In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

    P Lusso;P D Markham;E Tschachler;F di Marzo Veronese

  • Classification of HHV-6A and HHV-6B as distinct viruses.

    Dharam Ablashi;Henri Agut;Roberto Alvarez-Lafuente;Duncan A. Clark

  • Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

    Paolo Lusso;Barbara Ensoli;Phillip D. Markham;Dharam V. Ablashi

  • Genomic analysis of the human B-lymphotropic virus (HBLV).

    SF Josephs;SZ Salahuddin;DV Ablashi;F Schachter

  • Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

    Zwi N. Berneman;Dharam V. Ablashi;Ge Li;Maureen Eger-Fletcher

  • Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients

    D.V Ablashi;H.B Eastman;C.B Owen;M.M Roman

  • Human B-lymphotropic virus (human herpesvirus-6).

    D.V. Ablashi;S.F. Josephs;A. Buchbinder;K. Hellman

  • Human herpesvirus-6 strain groups: a nomenclature

    D. Ablashi;H. Agut;Z. Berneman;G. Campadelli-Fiume

  • Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation.

    Louis Flamand;Jean Gosselin;Irina Stefanescu;Dharam Ablashi

  • Detection and Titration of Human Herpesvirus-8–Specific Antibodies in Sera From Blood Donors, Acquired Immunodeficiency Syndrome Patients, and Kaposi's Sarcoma Patients Using a Whole Virus Enzyme-Linked Immunosorbent Assay

    Louise G. Chatlynne;William Lapps;Michael Handy;Yao Q. Huang

  • Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

    Philip E. Pellett;D. J. Wright;E. A. Engels;D. V. Ablashi

  • Upregulation of the 2-5A Synthetase/RNase L Antiviral Pathway Associated with Chronic Fatigue Syndrome

    Robert J. Suhadolnik;Nancy L. Reichenbach;Patricia Hitzges;Robert W. Sobol

  • Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).

    Dharam V. Ablashi;Paolo Lusso;Chia-Ling Hung;S. Zaki Salahuddin

  • Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)

    Louise G. Chatlynne;Dharam V. Ablashi

  • Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report.

    D V Ablashi;W Lapps;M Kaplan;J E Whitman

Frequent Co-Authors

Robert C. Gallo
Robert C. Gallo University of South Florida
Louis Flamand
Louis Flamand Université Laval
Gary R. Pearson
Gary R. Pearson Georgetown University
Paolo Lusso
Paolo Lusso National Institutes of Health
Tetsushi Yoshikawa
Tetsushi Yoshikawa Fujita Health University
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Parkash S. Gill
Parkash S. Gill University of Southern California
Steven Jacobson
Steven Jacobson National Institutes of Health
Peter Biberfeld
Peter Biberfeld Karolinska Institute
Irmeli Lautenschlager
Irmeli Lautenschlager University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students complement their immunology background with nursing qualifications to expand their clinical skills and job prospects. For those seeking fast-track options, 12-month accelerated nursing programs offer a quick path to becoming a registered nurse, building on prior education or experience.

Entry-level nursing roles can also lead to specialization in immunology-related fields. The best easiest lpn programs to get into provide accessible options for those starting their nursing careers, which can later evolve into more advanced roles with further education.

For graduates interested in advanced clinical roles, pursuing easiest online nurse practitioner programs allows for flexible learning while gaining in-depth patient care expertise. Some nurse practitioners focus in mental health, linking immunological research with psychiatric care. For these professionals, online pmhnp programs with clinical placement ensure hands-on experience in mental health settings, crucial for advancing their careers.

Overall, integrating immunology studies with nursing pathways can lead to fulfilling careers in healthcare, research, and patient advocacy, supported by a wide range of accessible and accelerated online degree options.

Best Scientists Citing Dharam V. Ablashi

Trending Scientists

Recently Published Articles